IRIS Accounts Production v25.1.3.33 03663271 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh036632712023-12-31036632712024-12-31036632712024-01-012024-12-31036632712022-12-31036632712023-01-012023-12-31036632712023-12-3103663271ns15:EnglandWales2024-01-012024-12-3103663271ns14:PoundSterling2024-01-012024-12-3103663271ns10:Director12024-01-012024-12-3103663271ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3103663271ns10:SmallEntities2024-01-012024-12-3103663271ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3103663271ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3103663271ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103663271ns10:FullAccounts2024-01-012024-12-3103663271ns10:Director22024-01-012024-12-3103663271ns10:CompanySecretary12024-01-012024-12-3103663271ns10:RegisteredOffice2024-01-012024-12-3103663271ns5:CurrentFinancialInstruments2024-12-3103663271ns5:CurrentFinancialInstruments2023-12-3103663271ns5:Non-currentFinancialInstruments2024-12-3103663271ns5:Non-currentFinancialInstruments2023-12-3103663271ns5:ShareCapital2024-12-3103663271ns5:ShareCapital2023-12-3103663271ns5:RetainedEarningsAccumulatedLosses2024-12-3103663271ns5:RetainedEarningsAccumulatedLosses2023-12-3103663271ns5:PlantMachinery2023-12-3103663271ns5:FurnitureFittings2023-12-3103663271ns5:ComputerEquipment2023-12-3103663271ns5:PlantMachinery2024-01-012024-12-3103663271ns5:FurnitureFittings2024-01-012024-12-3103663271ns5:ComputerEquipment2024-01-012024-12-3103663271ns5:PlantMachinery2024-12-3103663271ns5:FurnitureFittings2024-12-3103663271ns5:ComputerEquipment2024-12-3103663271ns5:PlantMachinery2023-12-3103663271ns5:FurnitureFittings2023-12-3103663271ns5:ComputerEquipment2023-12-3103663271ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3103663271ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3103663271ns5:WithinOneYear2024-12-3103663271ns5:WithinOneYear2023-12-3103663271ns5:BetweenOneFiveYears2024-12-3103663271ns5:BetweenOneFiveYears2023-12-3103663271ns5:AllPeriods2024-12-3103663271ns5:AllPeriods2023-12-3103663271ns5:DeferredTaxation2023-12-3103663271ns5:DeferredTaxation2024-01-012024-12-3103663271ns5:DeferredTaxation2024-12-31
REGISTERED NUMBER: 03663271 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 December 2024

for

Eurostar Scientific Limited

Eurostar Scientific Limited (Registered number: 03663271)






Contents of the Financial Statements
for the year ended 31 December 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Eurostar Scientific Limited

Company Information
for the year ended 31 December 2024







DIRECTORS: P J Rule
Miss J Rule





SECRETARY: P J Rule





REGISTERED OFFICE: 113 Century Building
Brunswick Business Park
Liverpool
Merseyside
L3 4BL





REGISTERED NUMBER: 03663271 (England and Wales)

Eurostar Scientific Limited (Registered number: 03663271)

Statement of Financial Position
31 December 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 6,489 6,387

CURRENT ASSETS
Stocks 6 60,549 70,061
Debtors 7 380,469 401,176
Cash at bank 100,824 149,230
541,842 620,467
CREDITORS
Amounts falling due within one year 8 (163,105 ) (247,285 )
NET CURRENT ASSETS 378,737 373,182
TOTAL ASSETS LESS CURRENT
LIABILITIES

385,226

379,569

CREDITORS
Amounts falling due after more than one year 9 (4,160 ) (14,933 )

PROVISIONS FOR LIABILITIES 11 (1,233 ) (1,216 )
NET ASSETS 379,833 363,420

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 379,831 363,418
379,833 363,420

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Eurostar Scientific Limited (Registered number: 03663271)

Statement of Financial Position - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 June 2025 and were signed on its behalf by:





P J Rule - Director


Eurostar Scientific Limited (Registered number: 03663271)

Notes to the Financial Statements
for the year ended 31 December 2024

1. STATUTORY INFORMATION

The principal activity of Eurostar Scientific Limited is that of wholesale of pharmaceutical goods.

The company is a private company limited by shares, and is incorporated in England and Wales. The address of the registered office address is 113 Century Building Brunswick Business Park, Liverpool, Merseyside, L3 4BL. The registered company number is 03663271.

The functional and presentational currency of the financial statements is the Pound Sterling (£), Monetary amounts in these financial statements are rounded to the nearest £.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below.

These policies have been consistently applied to all years presented, unless otherwise stated.

Basis of preparation
The financial statements are prepared on the going concern basis under the historical cost convention and comply with the United Kingdom Accounting Standards and Companies Act 2006.

Going concern
No material uncertainties that may cast doubt about the ability of the company to continue as a going concern have been identified by the directors. The directors therefore consider it appropriate to prepare the financial statements on the going concern basis.

Revenue
Turnover is measured at the fair value of the consideration received or receivable, and represents amounts receivable for goods excluding discounts, rebates, value added tax and other sales.

Income is recognised when good have been delivered to the customer such that risk and rewards of ownership has been transferred to them.

Eurostar Scientific Limited (Registered number: 03663271)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

3. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided at the following annual rates so as to write off their cost less residual amounts over their estimated useful economic lives. Assets are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the assets carrying amount exceeds its recoverable amount.

Plant and machinery- 15% on reducing balance
Fixtures and fittings-15% on reducing balance
Computer and equipment-15% on reducing balance


The residual values and useful lives of assets are reviewed and adjusted if appropriate at each statement of financial position date.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The following assets and liabilities are classified as financial instruments - trade debtors, trade creditors, bank loans and directors' loans.

Bank loans are initially measured at the present value of future payments, discounted at a market rate of interest, and subsequently at amortised cost using the effective interest method.

Directors' loans (being repayable on demand), trade debtors and trade creditors are measured at the discounted amount of the cash or other consideration expected to be paid or received.

Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Eurostar Scientific Limited (Registered number: 03663271)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment of assets
Assets not measured at fair value are reviewed for any indications that the asset may be impaired at each statement of financial position date. If such indications exists the recoverable amount of the asset or the assets cash generating unit is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

Any losses arising from impairment are recognised in the Statement of Comprehensive Income under the appropriate heading.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 5 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 January 2024 1,485 8,005 24,831 34,321
Additions - 1,247 - 1,247
At 31 December 2024 1,485 9,252 24,831 35,568
DEPRECIATION
At 1 January 2024 1,428 6,894 19,612 27,934
Charge for year 8 354 783 1,145
At 31 December 2024 1,436 7,248 20,395 29,079
NET BOOK VALUE
At 31 December 2024 49 2,004 4,436 6,489
At 31 December 2023 57 1,111 5,219 6,387

Eurostar Scientific Limited (Registered number: 03663271)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

6. STOCKS
2024 2023
£    £   
Stocks 60,549 70,061

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 367,641 382,274
Other debtors 12,828 18,902
380,469 401,176

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,648 10,000
Trade creditors 139,145 204,007
Taxation and social security 9,611 7,679
Other creditors 3,701 25,599
163,105 247,285

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 4,160 14,933

10. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 18,770 25,436
Between one and five years 23,463 16,957
42,233 42,393

11. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 1,233 1,216

Eurostar Scientific Limited (Registered number: 03663271)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

11. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 January 2024 1,216
Charge to Income Statement during year 17
Balance at 31 December 2024 1,233